Monocyte chemoattractant protein 1 (MCP-1) gene polymorphism is not associated with severe and cerebral malaria in

Naowarut Dechkum1, Hathairad Hananantachai, Jintana Patarapotikul

  • 1Department of Microbiology and Immunology, Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol Univeristy, Bangkok 10400, Thailand.

Insights

Monocyte chemoattractant protein 1 (MCP-1) gene variations are not linked to severe or cerebral malaria in Thailand. This study suggests MCP-1 does not cause malaria severity in this population.

Area of Science:

  • Genetics
  • Immunology
  • Infectious Diseases

Background:

  • Cerebral malaria pathogenesis involves central nervous system inflammation.
  • Monocyte chemoattractant protein 1 (MCP-1) is a key chemokine in inflammatory processes.

Purpose of the Study:

  • To investigate the association between MCP-1 gene polymorphisms and severe or cerebral malaria in a Thai population.
  • To determine if MCP-1 genetic variations contribute to malaria severity.

Main Methods:

  • Analysis of five single nucleotide polymorphisms (SNPs) in the MCP-1 promoter and one in intron 1.
  • Genotyping performed using PCR-RFLP, PCR-SSP, and direct sequencing.
  • Haplotype analysis conducted on SNPs with significant linkage disequilibrium.

Main Results:

  • No significant differences in genotype or allele frequencies for any analyzed MCP-1 SNPs between mild, severe, and cerebral malaria groups.
  • Four major haplotypes were estimated due to strong linkage disequilibrium among four SNPs.
  • The most common haplotype identified was GGAC.

Conclusions:

  • MCP-1 gene polymorphisms are not associated with malaria severity in the studied Thai population.
  • These findings imply that MCP-1 does not play a causal role in the development of malaria severity.